Hexagon Capital Partners LLC Astrazeneca PLC Transaction History
Hexagon Capital Partners LLC
- $546 Million
- Q4 2024
A detailed history of Hexagon Capital Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 3,555 shares of AZN stock, worth $268,047. This represents 0.04% of its overall portfolio holdings.
Number of Shares
3,555
Previous 4,723
24.73%
Holding current value
$268,047
Previous $368,000
36.96%
% of portfolio
0.04%
Previous 0.07%
Shares
16 transactions
Others Institutions Holding AZN
# of Institutions
1,358Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.55 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.09 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.83 Billion0.48% of portfolio
-
Wellington Management Group LLP Boston, MA37MShares$2.79 Billion0.46% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.81 Billion0.13% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $234B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...